Ordeniza, Elvira F.
HRN: 05-46-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/03/2023
11/10/2023
IV
1.5g
Q6
CAP-MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes